READMISSION AND MORTALITY ASSOCIATED WITH HYPONATREMIA AT THE TIME OF DISCHARGE IN PATIENTS WITHOUT HEART FAILURE OR END-STAGE LIVER DISEASE

被引：0
|
作者：
Fuller, Brittany [1 ]
Harrison, Michael F. [1 ]
Castillo, Juan Cesar Fernandez [1 ]
Uppuluri, Sreekanth [1 ]
Kinni, Harish [1 ]
Olarte-Merida, Karen [1 ]
Paje, David [1 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [1] High morbidity and mortality in end-stage liver disease and heart failure
    Brown, Cristal L.
    Hammill, Bradley G.
    Qualls, Laura G.
    Curtis, Lesley H.
    Muir, Andrew J.
    HEPATOLOGY, 2014, 60 : 964A - 965A
  • [2] Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease
    Drechsler, Christiane
    Kalim, Sahir
    Wenger, Julia B.
    Suntharalingam, Pirianthini
    Hod, Tammy
    Thadhani, Ravi I.
    Karumanchi, S. Ananth
    Wanner, Christoph
    Berg, Anders H.
    KIDNEY INTERNATIONAL, 2015, 87 (06) : 1201 - 1208
  • [3] Hyponatremia increases the risk of pretransplant mortality and morbidiry in pediatric patients with end-stage liver disease
    Carey, R
    Alonso, M
    Balistreri, W
    Bucuvalas, J
    Ryckman, F
    Tiao, G
    Yazigi, N
    HEPATOLOGY, 2005, 42 (04) : 323A - 323A
  • [4] Heart disease in patients with end-stage liver disease
    Colunga Blanco, S.
    Corros Vicente, C.
    Garcia Campos, A.
    Velasco Alonso, E.
    Diaz Pelaez, E.
    Lopez Iglesias, F.
    Martin Fernandez, M.
    De La Hera Galarza, J. M.
    Lambert Rodriguez, J. L.
    Moris De La Tassa, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 315 - 315
  • [5] Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation
    Fraley, DS
    Burr, R
    Bernardini, J
    Angus, D
    Kramer, DJ
    Johnson, JP
    KIDNEY INTERNATIONAL, 1998, 54 (02) : 518 - 524
  • [6] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [7] Dobutamine and mortality in end-stage heart failure
    Ebell, M
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (04) : 756 - 756
  • [8] Diastolic Dysfunction in Patients With End-Stage Liver Disease is Associated With Development of Heart Failure Early After Liver Transplantation
    Dowsley, Taylor F.
    Bayne, David B.
    Langnas, Alan N.
    Dumitru, Ioana
    Windle, John R.
    Porter, Thomas R.
    Raichlin, Eugenia
    TRANSPLANTATION, 2012, 94 (06) : 646 - 651
  • [9] ANALYZING HOSPITAL READMISSIONS IN END-STAGE RENAL DISEASE PATIENTS WITH AND WITHOUT HEART FAILURE
    Ustaris, Linda-Marie
    Goolsarran, Nirvani
    Mallipattu, Sandeep
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 592 - 592
  • [10] Diastolic Dysfunction in Patients with End-Stage Liver Disease Is Associated with Development of Heart Failure Early after Liver Transplantation
    Dowsley, Taylor F.
    Bayne, David B.
    Langnas, Alan N.
    Dumitru, Ioana
    Windle, John R.
    Porter, Thomas R.
    Raichlin, Eugenia
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S19 - S19
12345